FDA Clears Magstim Transcranial Magnetic Stimulation System Horizon 3.0 with StimGuide Pro
January 30, 2024 09:18 ET
|
Magstim EGI
FDA clears Magstim TMS System Horizon 3.0 with StimGuide Pro providing treatment for patients patients with depressive or obsessive-compulsive conditions
Antidepressant Market Poised for Growth, Forecasts High Demand by 2030
January 23, 2024 03:03 ET
|
Research and Markets
Dublin, Jan. 23, 2024 (GLOBE NEWSWIRE) -- The "Antidepressant Market Report: Trends, Forecast and Competitive Analysis to 2030" report has been added to ResearchAndMarkets.com's offering. The...
Major Depressive Disorder: New Insight-Focused Report Forecasts a Landscape Shifting 2019-2029
January 22, 2024 12:18 ET
|
Research and Markets
Dublin, Jan. 22, 2024 (GLOBE NEWSWIRE) -- The "Major Depressive Disorder - Eight-Market Drug Forecast and Market Analysis - Update" report has been added to ResearchAndMarkets.com's offering. A...
Unlocking Insights into Obsessive-Compulsive Disorder (OCD) Market: A Comprehensive Analysis and Forecast (2019-2032)
September 18, 2023 04:23 ET
|
Research and Markets
Dublin, Sept. 18, 2023 (GLOBE NEWSWIRE) -- The "Obsessive-Compulsive Disorder - Market Insight, Epidemiology And Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering. ...
North America Dominates Global Post-Traumatic Stress Disorder Therapeutics Market in 2022, Asia-Pacific Set for Rapid Growth
July 20, 2023 09:38 ET
|
Research and Markets
Dublin, July 20, 2023 (GLOBE NEWSWIRE) -- The "Post-Traumatic Stress Disorder Therapeutics Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering. This...
Post-traumatic Stress Disorder Treatment Global Market Report 2022: Featuring Jazz Pharmaceuticals, Madrigal Mental Care, Allergan, Otsuka & More
January 24, 2023 04:18 ET
|
Research and Markets
Dublin, Jan. 24, 2023 (GLOBE NEWSWIRE) -- The "Post-traumatic Stress Disorder Treatment Market, by Drug Class, by Route of Administration, by Age Group, by Distribution Channel and by Region - Size,...
Global Narcolepsy Therapeutics Market Report to 2028: Growing Healthcare Expenditures and Increasing Prevalence of Neurological Conditions are Driving Factors
November 10, 2022 07:08 ET
|
Research and Markets
Dublin, Nov. 10, 2022 (GLOBE NEWSWIRE) -- The "Global Narcolepsy Therapeutics Market Size, Share & Industry Trends Analysis Report By Type, By Product (Sodium Oxybate, Selective Serotonin...
Intermountain Healthcare Researchers Find Most Commonly Prescribed Class of Anti-Depressant Medications Do Not Reduce COVID Severity
November 09, 2022 09:00 ET
|
Intermountain Healthcare
Salt Lake City, UT, Nov. 09, 2022 (GLOBE NEWSWIRE) -- A new study by researchers at Intermountain Healthcare in Salt Lake City finds that the most commonly prescribed class of anti-depressants does...
Global Depression Treatment Market Report 2022 to 2032: Featuring AbbVie, Jubilant Generics, Sanis Health, Abbott Laboratories and Aurobindo Pharma Among Others
November 04, 2022 08:46 ET
|
Research and Markets
Dublin, Nov. 04, 2022 (GLOBE NEWSWIRE) -- The "Depression Treatment Market" report has been added to ResearchAndMarkets.com's offering.A recent market study published on the depression treatment...
Depression Drugs Global Market Report 2022: Emergence of Novel Techniques for the Development of Antidepressants With Minimal Side-Effects Presents Opportunities
October 13, 2022 07:58 ET
|
Research and Markets
Dublin, Oct. 13, 2022 (GLOBE NEWSWIRE) -- The "Depression Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been added to ...